Afatinib versus methotrexate as second-line treatment for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) progressing on or after platinum-based therapy: LUX-Head & Neck 3 phase Ill trial.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Guo, Y[Guo, Ye] | - |
dc.contributor.author | Ahn, MJ[Ahn, Myung-Ju] | - |
dc.contributor.author | Chan, ATC[Chan, Anthony T. C.] | - |
dc.contributor.author | Wang, CH[Wang, Cheng-Hsu] | - |
dc.contributor.author | Kang, JH[Kang, Jin Hyoung] | - |
dc.contributor.author | Kim, SB[Kim, Sung-Bae] | - |
dc.contributor.author | Bello, MD[Bello, Maximino De Guzman] | - |
dc.contributor.author | Arora, RS[Arora, Rajendra Singh] | - |
dc.contributor.author | Zhang, QY[Zhang, Qingyuan] | - |
dc.contributor.author | He, XH[He, Xiaohui] | - |
dc.contributor.author | Li, P[Li, Ping] | - |
dc.contributor.author | Dechaphunkul, A[Dechaphunkul, Arunee] | - |
dc.contributor.author | Kumar, V[Kumar, Vijay] | - |
dc.contributor.author | Kamble, K[Kamble, Krishna] | - |
dc.contributor.author | Li, W[Li, Wei] | - |
dc.contributor.author | Kandil, A[Kandil, Alaa] | - |
dc.contributor.author | Cohen, EEW[Cohen, Ezra E. W.] | - |
dc.contributor.author | Geng, Y[Geng, Yuan] | - |
dc.contributor.author | Zografos, L[Zografos, Lef] | - |
dc.contributor.author | Tang, PZ[Tang, Ping Zhang] | - |
dc.date.accessioned | 2021-07-28T18:45:31Z | - |
dc.date.available | 2021-07-28T18:45:31Z | - |
dc.date.created | 2020-01-28 | - |
dc.date.issued | 2019-05-20 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://scholarx.skku.edu/handle/2021.sw.skku/9893 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | - |
dc.title | Afatinib versus methotrexate as second-line treatment for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) progressing on or after platinum-based therapy: LUX-Head & Neck 3 phase Ill trial. | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, MJ[Ahn, Myung-Ju] | - |
dc.identifier.doi | 10.1200/JCO.2019.37.15_suppl.6024 | - |
dc.identifier.wosid | 000487345805608 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, v.37, no.15 | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.citation.title | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.citation.volume | 37 | - |
dc.citation.number | 15 | - |
dc.type.rims | ART | - |
dc.type.docType | Meeting Abstract | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.